Compare MREO & NWPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of innovative therapeutics for rare diseases. The Company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
Northwest Pipe Co is a manufacturer of water-related infrastructure products. The company has two operating segments; Engineered Steel Pressure Pipe segment manufactures large-diameter, high-pressure steel pipeline systems for use in water infrastructure applications, which are related to drinking water systems. These products are also used for hydroelectric power systems, wastewater systems, seismic resiliency, and other applications, and Precast Infrastructure and Engineered Systems segment manufacture stormwater and wastewater technology products, high-quality precast and reinforced concrete products, including manholes, box culverts, vaults, and catch basins, pump lift stations, oil water separators, biofiltration, and other environmental and engineered solutions.